Stoke Therapeutics, Inc. (STOK) › Capital ExpendituresStoke Therapeutics, Inc. (STOK) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $935.0K2019: $1.64M2020: $1.05M2021: $1.20M2022: $3.96M2023: $1.62M2024: $203.0K2025: $670.0K$670.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$670.0K+230.0%2024$203.0K-87.4%2023$1.62M-59.2%2022$3.96M+230.2%2021$1.20M+14.3%2020$1.05M-35.8%2019$1.64M+74.9%2018$935.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share